Publication | Closed Access

Biology-oriented drug synthesis (BIODS) of 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl aryl ether derivatives, in vitro α-amylase inhibitory activity and in silico studies

Medicinal ChemistryDerivativesBiochemistryNatural SciencesMedicineDiversity-oriented SynthesisRational Drug DesignOrganic ChemistrySilico StudiesDrug DevelopmentChemical BiologyPharmacologyBiology-oriented Drug SynthesisPharmaceutical ChemistryInhibitory ActivityDrug DiscoveryNatural Product Synthesis